Investigators studied the relationship between migraine, triptans, and asthma retrospectively, and found that having migraines or taking triptans does not appear to be associated with development of asthma.…
The FDA’s Ophthalmic Devices Advisory Committee has concluded that LASIK is safe and well accepted, but the panel did site some concerns including the possibility of cataracts, endothelial…
Dan Labriola, ND, Director, Naturopathic Services, Swedish Cancer Institute, Seattle, WA, discusses unregulated botanical and vitamin products. Sponsored by The Doctor’s Channel
Thomas K. Byrne, MD, Professor, General and Gastrointestinal Surgery, Director, Bariatric Surgery Program, Medical University of South Carolina, discusses surgical weight loss. References and Resources Blanc PM, Lagoutte…
Ralph W. Aye, MD, Program Leader, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, discusses the possibility of the use of sputum analysis for lung cancer screening. References…
Ralph W. Aye, MD, Program Leader, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, shares his thoughts on the cost of lung cancer screening. Sponsored by The Doctor’s…
John S. Ikonomidis, MD, PhD, Associate Professor, Cardiothoracic Surgery, Medical University of South Carolina, discusses the use of cardiac assist devices. References and Resources Pitsis AA, Kelpis TG,…
For patients on continuous medication for pain relief in late-stage illness, the FDA has approved methylnaltrexone bromide (Relistor) injection for treatment of opioid-induced constipation. References and Resources FDA…
According to results of a multicenter randomized clinical trial, patients with advanced NSCLC derived no benefit from the addition of sorafenib (Nexavar) to chemotherapy. References and Resources Scagliotti…
Vivek K. Mehta, MD, Radiation Oncologist, Director, Center for Advanced Targeted Radiotherapies, Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA, discusses advances in partial breast radiation. References…
